INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›health›Some Wet Macular Degeneration Patients May Someday Need Eye Injections Only Twice a Year After Kodiak Trial
health

Some Wet Macular Degeneration Patients May Someday Need Eye Injections Only Twice a Year After Kodiak Trial

By Info60 US Desk•Summary of reporting by Medical Daily•1d ago•0 views•
Some Wet Macular Degeneration Patients May Someday Need Eye Injections Only Twice a Year After Kodiak Trial
Kodiak's Zenkuda matched Eylea in a Phase 3 wet AMD trial, and 54% of patients reached six-month dosing. What families can ask a retina doctor.
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

Dad says he went permanently blind

Dad says he went permanently blind

New York Post

I'm a woman in my 20s and I'm not have the sex I want. I know what's holding me back.

I'm a woman in my 20s and I'm not have the sex I want. I know what's holding me back.

Slate

Millions of cancer cases are linked to 5 common infections: study

Millions of cancer cases are linked to 5 common infections: study

New York Post

45-year-old man died after ER sent him home without antibiotics, lawsuit says

45-year-old man died after ER sent him home without antibiotics, lawsuit says

OregonLive.com

19 Harmless Symptoms That Are Major Medical Red Flags

19 Harmless Symptoms That Are Major Medical Red Flags

BuzzFeed

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!